| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/19/2006 | EP1681062A1 Antibacterial drug for propionibacterium acnes |
| 07/19/2006 | EP1680413A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 07/19/2006 | EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 07/19/2006 | EP1393277B1 USE OF NF-Kappa-B INHIBITORS TO TREAT DRY EYE DISORDERS |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | CN1805749A New pharmaceutical uses of staurosporine derivatives |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264820C Ocular hypotensive lipids |
| 07/19/2006 | CN1264517C Application of Netilmicin sulfate in preparation of eye drops |
| 07/18/2006 | US7078426 Central nervous system disorders |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078422 Activator for peroxisome proliferator-activated receptor |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078412 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane in salt form, particularly bromide or trifluoroacetate, for treatment of respiratory disorders, alone or in combination with other bronchodilatory compounds |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078048 A topical formulation for treating rosacea ( a facial dermatitis ) contains a combination of: an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 07/18/2006 | CA2313629C Method for transferring one or more active ingredients between different phase carriers |
| 07/18/2006 | CA2132007C Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
| 07/13/2006 | WO2006073786A2 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073126A1 Preventive and remedy for dry eye associated with chronic graft versus host disease |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072792A2 Compounds which bind to the active site of protein kinase enzymes |
| 07/13/2006 | WO2005110364A3 Drug delivery systems and methods for treatment of an eye |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154972 Amino acids with affinity for the alpha-2-delta-protein |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154901 Treating patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent comeal epithelial erosion by topically administering an effective amount of tetracycline or derivative to eye |
| 07/13/2006 | US20060154899 Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060153938 Eye -Rinse Solution Made of Grape juice |
| 07/13/2006 | US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment |
| 07/13/2006 | US20060153880 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153770 Method of treating tumors |
| 07/12/2006 | EP1679308A1 Novel indazole derivative |
| 07/12/2006 | EP1679074A1 Therapeutic agent for keratoconjunctive disorder |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1679059A2 Utilization of vinpocetine to avoid complications in particular those associated to hearing which occur with epilepsy, and treatment thereof |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP1303499B1 Tetrazole derivatives |
| 07/12/2006 | EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders |
| 07/12/2006 | CN1802377A Tricyclic compound |
| 07/12/2006 | CN1799559A Chinese medicinal gel formulation, its preparation process and quality control method |
| 07/12/2006 | CN1799557A Chinese medicinal gel formulation, its preparation process and quality control method |
| 07/12/2006 | CN1799547A Pirenzepine eyes gel containing hyaluronic acid |
| 07/12/2006 | CN1799545A Compound ocular medicinal composition |
| 07/12/2006 | CN1799540A Use of okadaic acid in preparation of medicine for resisting glaucoma operation scar |
| 07/12/2006 | CN1263770C Novel peptides and medicinal uses thereof |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263755C Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 07/12/2006 | CN1263733C Substituted phenyl derivatives, their preparation and use |
| 07/12/2006 | CN1263726C Process and intermediates to prepare latanoprost |
| 07/12/2006 | CN1263512C Concomitant drugs for treating glaucoma |
| 07/12/2006 | CN1263485C Eyesight-improving pill and preparing technique |
| 07/12/2006 | CN1263463C Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 07/12/2006 | CN1263451C Cinrofloxacin eye preparation formula and its using method |
| 07/11/2006 | US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | US7074778 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | US7074408 Use of integrin antagonists to inhibit angiogenesis |
| 07/11/2006 | US7074406 Treating allergic diseases with humanized anti-CD40L antibody |
| 07/11/2006 | CA2395114C 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 07/11/2006 | CA2319201C Celecoxib compositions |
| 07/11/2006 | CA2309172C Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions |
| 07/11/2006 | CA2198751C Dihydro-2,3-benzodiazepine derivatives |
| 07/06/2006 | WO2006070927A1 Pyrimidinylisoxazol derivative |
| 07/06/2006 | WO2006070874A1 Hypoxic response promoter |
| 07/06/2006 | WO2006070780A1 Par-2 agonist |
| 07/06/2006 | WO2006052893A3 Substituted pyrrolidone compounds as ep4 agonists |
| 07/06/2006 | US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 07/06/2006 | US20060148852 Visual function disorder improving agents |
| 07/06/2006 | US20060148829 Means for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti |
| 07/06/2006 | US20060148825 1-[Alkyl], 1-[(heteroaryl) alkyl] and 1-[(Aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor |
| 07/06/2006 | US20060148805 Opthalmic compositions for treating ocular hypertension |
| 07/06/2006 | US20060148802 Use of compounds that stimulate cgmp |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148675 Methods of reducing angiogenesis |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2591403A1 Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676845A1 New quinazoline derivatives |
| 07/05/2006 | EP1676579A2 Use of sub-antimicrobial tetracyclines for treating ocular rosacea |